Company Overview of Archemix Corp.
Archemix Corp. is a biotechnology company that discovers, develops, and commercializes therapeutic aptamers for the prevention and treatment of chronic and acute diseases in Massachusetts. Its aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases. Archemix Corp. was incorporated in 2000 and is based in San Francisco, California.
601 Montgomery Street
San Francisco, CA 94111
Founded in 2000
Key Executives for Archemix Corp.
Similar Private Companies By Industry
|Wellstat Therapeutics Corporation||United States|
|SteadyMed Therapeutics, Inc.||United States|
|BioPheresis Technologies, Inc.||United States|
|PPD Biomarker Discovery Sciences, LLC||United States|
|QIAGEN North American Holdings Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Archemix Corp., please visit www.archemix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.